111 Results for "

Nav1.7

" in MedChemExpress (MCE) Product Catalog:
Products (111)

111 Results for "Nav1.7" in MCE Product Catalog:

  • Categories Recommended:
    More
4
4 Cited Publications
Cat. No.: HY-N6691
CAS No.: 71-62-5
Synonyms: 3-Veratroylveracevine
Veratridine (3-Veratroylveracevine) is a plant neurotoxin, a voltage-gated sodium channels (VGSCs) agonist. Veratridine inhibits the peak current of Nav1.7, with an IC50 of 18.39 µM. Veratridine regulates sodium ion channels mainly by activating sodium ion channels, preventing channel inactivation and increasing sodium ion flow .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12883
CAS No.: 1235403-62-9
Purity:  99.87%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

PF 05089771 is a potent, orally active and selective arylsulfonamide Nav1.7 inhibitor, with IC50 values of 11 nM, 12 nM, 13 nM, 171 nM and 8 nM for hNav1.7, cynNav1.7, dogNav1.7, ratNav1.7, and musNav1.7, respectively. PF 05089771 is under the study for pain and diabetic neuropathy .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P10234A
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Poneratoxin acetate is the acetate salt form of Poneratoxin (HY-P10234). Poneratoxin acetate is the modulator for voltage-gated sodium channel (NaV, EC50 for NaV1.6 and NaV1.7 is 97 nM and 2.3 µM), that lowers the voltage threshold for activation and inhibits the inactivation of channels, enhances the excitability of neurons, and leads to the transmission of pain signals .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-105285
CAS No.: 946846-83-9
Purity:  99.54%
Synonyms: Neu-P11
Piromelatine (Neu-P11) is a melatonin MT1/MT2 receptor agonist, serotonin 5-HT1A/5-HT1D agonist, and serotonin 5-HT2B antagonist. Piromelatine (Neu-P11) possesses sleep promoting, analgesic, anti-neurodegenerative, anxiolytic and antidepressant potentials. Piromelatine (Neu-P11) also possesses pain-related P2X3, TRPV1, and Nav1.7 channel-inhibition capacities .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0478
CAS No.: 466-26-2
Synonyms: Bullatine B
Neoline (Bullatine B) is the active ingredient of the active ingredient (PA), which can be used to cure the disease. Neoline Flow Suppression Nav1.7 Electrical Flow Control (VGSC), improve diabetes mechanical pain sensitivity. Neoline has a list of compounds that can be used, research on its use, and the quality of its processing during processing in pain .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12811
CAS No.: 1235397-05-3
Purity:  99.29%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

PF-04856264 is a potent and selective Nav1.7 inhibitor, with IC50s of 28, 131, 19, and 42 nM for human, mouse, cynomolgus monkey and dog Nav1.7, respectively. PF-04856264 has low potency against the rat Nav1.7 channel. PF-04856264 shows analgesic effect .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-131182
CAS No.: 1450595-86-4
Purity:  99.61%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

DS-1971a is a potent, selective, and orally active NaV1.7 inhibitor, with IC50s of 22.8 and 59.4 nM for hNaV1.7 and mNaV1.7, respectively. DS-1971a exerts analgesic effects .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1221A
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

ProTx II TFA is a selective blocker of Nav1.7 sodium channels, with an IC50 value of 0.3 nM and a Ki of 0.389 nM against human NaV1.7. ProTx II TFA selectively blocks spinal cord NaV1.7 by reducing conductance and altering voltage dependence of activation, preferentially binds to the splice region of aNaV1.5, and can also block sodium channel subtypes such as Nav1.4 and Nav1.6. ProTx II TFA alleviates thermal hyperalgesia in diabetic mice and prevents the propagation of action potentials in nociceptors. ProTx II TFA can be used for research related to painful diabetic neuropathy and pain disorders .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-133910
CAS No.: 849000-18-6
Purity:  98.02%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Lu AE98134, an activator of voltage-gated sodium channels, acts as a partly selective Nav1.1 channels positive modulator. Lu AE98134 also increases the activity of Nav1.2 and Nav1.5 channels but not of Nav1.4, Nav1.6 and Nav1.7 channels. Lu AE98134 can be used to analyze pathophysiological functions of the Nav1.1 channel in various central nervous system diseases, including cognitive restoring in schizophrenia, et al .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100727
CAS No.: 1443373-17-8
Purity:  98.06%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

AM-2099 is a potent and selective inhibitor of voltage-gated sodium channel Nav1.7 with an IC50 of 0.16 μM for human Nav1.7.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1221
CAS No.: 484598-36-9
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

ProTx II is a selective blocker of Nav1.7 sodium channels, with an IC50 value of 0.3 nM and a Ki of 0.389 nM against human NaV1.7. ProTx II selectively blocks spinal cord NaV1.7 by reducing conductance and altering voltage dependence of activation, preferentially binds to the splice region of aNaV1.5, and can also block sodium channel subtypes such as Nav1.4 and Nav1.6. ProTx II alleviates thermal hyperalgesia in diabetic mice and prevents the propagation of action potentials in nociceptors. ProTx II can be used for research related to painful diabetic neuropathy and pain disorders .
loading...
    loading...
Cat. No.: HY-125079
CAS No.: 1233231-30-5
Purity:  98.33%
Synonyms: ANP-230
DSP-2230 is the orally active inhibitor for voltage-gated sodium channel that inhibits Nav1.7-, Nav1.8-, and Nav1.9-derived sodium currents with IC50s of 7.1 μM, 11.4 μM and 6.7 μM, respectively. DSP-2230 can be used to improve neuropathic pain .
loading...
    loading...
Cat. No.: HY-12796
CAS No.: 934240-30-9
Purity:  99.85%
Synonyms: Vixotrigine; GSK-1014802; CNV1014802
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Raxatrigine (GSK-1014802) is a novel small molecule state-dependent sodium channel blocker; Nav1.7 sodium channel inhibitor.
loading...
    loading...
Cat. No.: HY-12796A
CAS No.: 934240-31-0
Purity:  98.94%
Synonyms: Vixotrigine hydrochloride; GSK-1014802 hydrochloride; CNV1014802 hydrochloride
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Raxatrigine hydrochloride (GSK-1014802 hydrochloride) is a novel small molecule state-dependent sodium channel blocker; Nav1.7 sodium channel inhibitor.
loading...
    loading...
Cat. No.: HY-118952A
CAS No.: 1834610-75-1
Purity:  99.38%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

PF-06456384 trihydrochloride is an extremely potent and selective Nav1.7 sodium channel blocker (IC50: 0.01 nM for hNaV1.7; 75 nM for rNaV1.7; <0.1 nM for mNaV1.7). PF-06456384 trihydrochloride shows no significant analgesic efficacy in the mouse Formalin pain model .
loading...
    loading...
Cat. No.: HY-114237
CAS No.: 1494581-70-2
Purity:  99.69%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

GDC-0276 is a potent, selective, reversible and orally active NaV1.7 inhibitor with an IC50 value of 0.4 nM. GDC-0276 is well tolerated and exhibits a good pharmacokinetic profile. GDC-0276 has the potential for the treatment of pain and to address shortcomings of existing pain medications, such as addiction and off-target side effects .
loading...
    loading...
Cat. No.: HY-13985
CAS No.: 1355631-24-1
Purity:  99.99%
Nav1.7 inhibitor (compound II), a sulfonamide, is a potent Nav1.7 inhibitor. Nav1.7 inhibitor has the potential for a wide range of disorders, particularly pain, including acute pain, inflammatory pain and/or neuropathic pain .
loading...
    loading...
Cat. No.: HY-119934
CAS No.: 1494585-79-3
Purity:  99.65%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

NaV1.7 inhibitor-1 is an efficacious voltage-gated sodium channel (NaV) 1.7 inhibitor with an IC50 of 0.6 nM for hNaV1.7, exhibits 80-fold selectivity versus hNaV1.5 .
loading...
    loading...
Cat. No.: HY-112279
CAS No.: 1629063-81-5
Purity:  98.15%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

GNE-131 is a potent and selective inhibitor of human sodium channel NaV1.7, with an IC50 of 3 nM.
loading...
    loading...
Cat. No.: HY-139081
CAS No.: 1788063-52-4
Purity:  98.84%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

GDC-0310 is a selective acyl-sulfonamide Nav1.7 inhibitor, with an IC50 of 0.6 nM for hNav1.7 .
loading...
    loading...